A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine

NCT03962738 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

846

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Lasmiditan
DRUG: Placebo

Sponsor

Eli Lilly and Company